Cure4Cancer’s Post

The Bloomberg New Economy International Cancer Coalition recently concluded its annual meeting alongside the American Society of Clinical Oncology (ASCO) event, emphasizing the critical need for international cooperation and regulatory alignment to accelerate life-saving cancer treatments. Key Highlights: 1. The FDA's Role in International Cooperation - Richard Pazdur, Director of the FDA’s Oncology Center of Excellence, discussed the FDA's pivotal role in fostering global collaboration, with over 500 applications and 400 approvals in the past five years. This approach has significantly accelerated patient access to new therapies worldwide. 2. ASCO’s Global Efforts - Julie Gralow, ASCO's Chief Medical Officer, highlighted efforts to break down silos and enhance communication among oncologists in low- and middle-income countries through regional councils. 3. NCI’s Collaborative Vision - Kimryn Rathmell, Director of the National Cancer Institute, spoke on the shift towards greater collaboration and innovation in clinical trials, aiming to make them faster and more accessible globally. Established in 2021 the coalition has been a major driving force in fostering international collaborations. By leveraging technology and bringing together multiple stakeholders from both the public and private sectors we focus on: 1. Improving access to diagnostics 2. Enhancing patient-centric cancer clinical trials through technologies like liquid biopsy and telemedicine 3. Promoting regulatory harmonization to lower barriers to patient-centric care globally This year, we welcome new members Tolulope Adewole of MedServe, Jennifer Dent of BVGH, Julie Gralow of ASCO, Tufia Haddad, M.D. of the Mayo Clinic Comprehensive Cancer Centre and Artur Katz of Hospital Sírio-Libanês, who are leaders in oncology and global health, further strengthening its commitment to global health equity. Read More: https://bloom.bg/4b0kZtW #InternationalCancerCoalition #ASCO2024